Back

Post-acute and Chronic Kidney Function Outcomes of COVID-19 in Children and Adolescents: An EHR Cohort Study from the RECOVER Initiative

Li, L.; Zhou, T.; Lu, Y.; Chen, J.; Lei, Y.; Wu, Q.; Arnold, J.; Becich, M. J.; Bisyuk, Y.; Blecker, S.; Chrischilles, E.; Christakis, D. A.; Geary, C. R.; Jhaveri, R.; Lenert, L.; Liu, M.; Mirhaji, P.; Morizono, H.; Mosa, A. S. M.; Onder, A. M.; Patel, R.; Smoyer, W. E.; Taylor, B. W.; Williams, D. A.; Dixon, B. P.; Flynn, J. T.; Gluck, C.; Harshman, L. A.; Mitsnefes, M. M.; Modi, Z. J.; Pan, C. G.; Patel, H. P.; Verghese, P. S.; Forrest, C. B.; Denburg, M. R.; Chen, Y.

2024-06-26 epidemiology
10.1101/2024.06.25.24309488 medRxiv
Show abstract

We investigated the risks of post-acute and chronic adverse kidney outcomes of SARS-CoV-2 infection in the pediatric population via a retrospective cohort study using data from the RECOVER program. We included 1,864,637 children and adolescents under 21 from 19 childrens hospitals and health institutions in the US with at least six months of follow-up time between March 2020 and May 2023. We divided the patients into three strata: patients with pre-existing chronic kidney disease (CKD), patients with acute kidney injury (AKI) during the acute phase (within 28 days) of SARS-CoV-2 infection, and patients without pre-existing CKD or AKI. We defined a set of adverse kidney outcomes for each stratum and examined the outcomes within the post-acute and chronic phases after SARS-CoV-2 infection. In each stratum, compared with the non-infected group, patients with COVID-19 had a higher risk of adverse kidney outcomes. For patients without pre-existing CKD, there were increased risks of CKD stage 2+ (HR 1.20; 95% CI: 1.13-1.28) and CKD stage 3+ (HR 1.35; 95% CI: 1.15-1.59) during the post-acute phase (28 days to 365 days) after SARS-CoV-2 infection. Within the post-acute phase of SARS-CoV-2 infection, children and adolescents with pre-existing CKD and those who experienced AKI were at increased risk of progression to a composite outcome defined by at least 50% decline in estimated glomerular filtration rate (eGFR), eGFR <15 mL/min/1.73m2, End Stage Kidney Disease diagnosis, dialysis, or transplant. Lay abstractThis study examined the impact of COVID-19 on kidney health in children and adolescents under 21 years old in the United States. Using data from the RECOVER program, we analyzed the health records of 1,864,637 young individuals from 19 hospitals and health institutions between March 2020 and May 2023. The study focused on three groups: those with pre-existing chronic kidney disease (CKD), those who experienced acute kidney injury (AKI) during the initial COVID-19 infection, and those without any prior kidney issues. The results showed that children and adolescents who had COVID-19 were at a higher risk of developing serious kidney problems later on, even if they had no previous kidney conditions. This research highlights the long-term effects of COVID-19 on kidney health in young people and underscores the importance of monitoring kidney function in pediatric COVID-19 patients.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Journal of the American Society of Nephrology
52 papers in training set
Top 0.1%
39.7%
2
PLOS ONE
4510 papers in training set
Top 18%
10.2%
3
BMC Nephrology
13 papers in training set
Top 0.1%
6.4%
50% of probability mass above
4
Transplantation
13 papers in training set
Top 0.1%
4.3%
5
Scientific Reports
3102 papers in training set
Top 31%
4.0%
6
Kidney International
25 papers in training set
Top 0.1%
3.7%
7
Kidney360
22 papers in training set
Top 0.2%
3.3%
8
Journal of the American Heart Association
119 papers in training set
Top 2%
2.1%
9
Frontiers in Pharmacology
100 papers in training set
Top 2%
1.5%
10
BMC Medical Research Methodology
43 papers in training set
Top 0.8%
1.2%
11
American Journal of Epidemiology
57 papers in training set
Top 1%
1.0%
12
International Journal of Infectious Diseases
126 papers in training set
Top 3%
0.9%
13
eLife
5422 papers in training set
Top 53%
0.9%
14
JAMA Network Open
127 papers in training set
Top 4%
0.8%
15
Annals of Epidemiology
19 papers in training set
Top 0.5%
0.8%
16
PLOS Medicine
98 papers in training set
Top 4%
0.8%
17
Diabetologia
36 papers in training set
Top 0.9%
0.8%
18
Epidemiology
26 papers in training set
Top 0.6%
0.7%
19
Nature Communications
4913 papers in training set
Top 65%
0.6%
20
JMIR Public Health and Surveillance
45 papers in training set
Top 4%
0.6%
21
BMC Public Health
147 papers in training set
Top 7%
0.5%
22
BMC Medicine
163 papers in training set
Top 9%
0.5%